Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Hodentumoren
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1983) 6 (1): 16–20.
Published Online: 21 April 2009
...J. Schütte; K. Bremer; N. Niederle; B. Schoetensack; C.G. Schmidt; S. Seeber Die vorliegende retrospektive Untersuchung befaßt sich mit der sequentiell-alternierenden Chemotherapie metastasierender, nicht-seminomatöser Hodentumoren. Die therapeutische Wertigkeit der Zytostatikakombinationen...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1983) 6 (3): 144–147.
Published Online: 21 April 2009
... Überlebenszeiten entsprechen denen anderer Studien. Das Protokoll stellt eine wirksame Kombination in der Behandlung nicht-seminomatöser Hodentumoren dar. Hodentumoren Chemotherapie Cis-Platin © 1983 S. Karger AG, Basel 1983 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...